J. Goldman & Co’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$709K Sell
2,900
-63,081
-96% -$14.7M 0.02% 463
2025
Q4
$13.7M Buy
+65,981
New +$13M 0.36% 77
2023
Q3
Sell
-160,694
Closed -$26.6M 420
2023
Q2
$26.6M Buy
+160,694
New +$25.9M 0.97% 21
2022
Q4
Sell
-51,666
Closed -$8.44M 428
2022
Q3
$8.44M Buy
+51,666
New +$8.74M 0.4% 80

Other funds holding JNJ

J. Goldman & Co's JNJ Position: Q1 2026 in Review

J. Goldman & Co reduced its Johnson & Johnson (JNJ) stake by 96% in Q1 2026, selling an estimated $14.7M and leaving 2,900 shares worth $709K. The position accounts for 0.02% of the portfolio, ranked #463.

J. Goldman & Co first reported a position in JNJ in Q3 2022 and has held it in 4 quarters since. The position peaked at $26.6M in Q2 2023. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • J. Goldman & Co held 2,900 shares of Johnson & Johnson worth $709K as of Q1 2026.
  • J. Goldman & Co sold 63,081 Johnson & Johnson shares in Q1 2026, an estimated $14.7M.
  • Johnson & Johnson made up 0.02% of J. Goldman & Co's portfolio in Q1 2026, its #463 holding.
  • J. Goldman & Co first reported a position in Johnson & Johnson in Q3 2022 and has held it in 4 quarters since.
  • J. Goldman & Co's Johnson & Johnson position peaked at $26.6M in Q2 2023.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on J. Goldman & Co's 13F filing for Q1 2026, filed 15 May 2026.